Keybank National Association Neurocrine Biosciences Inc Transaction History
Keybank National Association
- $24.1 Billion
- Q2 2024
A detailed history of Keybank National Association transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Keybank National Association holds 3,057 shares of NBIX stock, worth $461,270. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,057
Previous 1,622
88.47%
Holding current value
$461,270
Previous $223,000
88.34%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NBIX
# of Institutions
641Shares Held
95.3MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$2.14 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.52 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$695 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$372 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$357 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.4B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...